Cha IJ - Search Results

1

Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans.

Shon JH, Yoon YR, Kim KA, Lim YC, Lee KJ, Park JY, Cha IJ, Flockhart DA, Shin JG. Shon JH, et al. Among authors: cha ij. Pharmacogenetics. 2002 Mar;12(2):111-9. doi: 10.1097/00008571-200203000-00005. Pharmacogenetics. 2002. PMID: 11875365 Clinical Trial.

2

Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19.

Kim KA, Shon JH, Park JY, Yoon YR, Kim MJ, Yun DH, Kim MK, Cha IJ, Hyun MH, Shin JG. Kim KA, et al. Among authors: cha ij. Clin Pharmacol Ther. 2002 Jul;72(1):90-9. doi: 10.1067/mcp.2002.126176. Clin Pharmacol Ther. 2002. PMID: 12152007 Clinical Trial.

3

Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism.

Shon JH, Yoon YR, Kim MJ, Kim KA, Lim YC, Liu KH, Shin DH, Lee CH, Cha IJ, Shin JG. Shon JH, et al. Among authors: cha ij. Br J Clin Pharmacol. 2005 May;59(5):552-63. doi: 10.1111/j.1365-2125.2005.02364.x. Br J Clin Pharmacol. 2005. PMID: 15842554 Free PMC article.

4

Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects.

Park JY, Shon JH, Kim KA, Jung HJ, Shim JC, Yoon YR, Cha IJ, Shin JG. Park JY, et al. Among authors: cha ij. J Clin Psychopharmacol. 2006 Apr;26(2):135-42. doi: 10.1097/01.jcp.0000203199.88581.c3. J Clin Psychopharmacol. 2006. PMID: 16633141 Clinical Trial.

5

Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin.

Shin JG, Park JY, Kim MJ, Shon JH, Yoon YR, Cha IJ, Lee SS, Oh SW, Kim SW, Flockhart DA. Shin JG, et al. Among authors: cha ij. Drug Metab Dispos. 2002 Oct;30(10):1102-7. doi: 10.1124/dmd.30.10.1102. Drug Metab Dispos. 2002. PMID: 12228186

6

Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner.

Liu KH, Kim MJ, Jung WM, Kang W, Cha IJ, Shin JG. Liu KH, et al. Among authors: cha ij. Drug Metab Dispos. 2005 Feb;33(2):209-13. doi: 10.1124/dmd.104.001438. Epub 2004 Nov 10. Drug Metab Dispos. 2005. PMID: 15537834

7

Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population.

Lee SS, Kim KM, Thi-Le H, Yea SS, Cha IJ, Shin JG. Lee SS, et al. Among authors: cha ij. Ther Drug Monit. 2005 Apr;27(2):208-10. doi: 10.1097/01.ftd.0000153402.91854.42. Ther Drug Monit. 2005. PMID: 15795654

8

High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry.

Kim MJ, Kim H, Cha IJ, Park JS, Shon JH, Liu KH, Shin JG. Kim MJ, et al. Among authors: cha ij. Rapid Commun Mass Spectrom. 2005;19(18):2651-8. doi: 10.1002/rcm.2110. Rapid Commun Mass Spectrom. 2005. PMID: 16124035

9

Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population.

Lee SS, Jung HJ, Park JS, Cha IJ, Cho DY, Shin JG. Lee SS, et al. Among authors: cha ij. Mol Biol Rep. 2010 Jan;37(1):213-7. doi: 10.1007/s11033-009-9608-1. Epub 2009 Jul 8. Mol Biol Rep. 2010. PMID: 19585271

10

Inhibitory effects of fruit juices on CYP3A activity.

Kim H, Yoon YJ, Shon JH, Cha IJ, Shin JG, Liu KH. Kim H, et al. Among authors: cha ij. Drug Metab Dispos. 2006 Apr;34(4):521-3. doi: 10.1124/dmd.105.007930. Epub 2006 Jan 13. Drug Metab Dispos. 2006. PMID: 16415112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters